Cassava Sciences Current Deferred Revenue (Quarterly) Analysis

Cassava Sciences, Inc. (SAVA)

2.19 -0.13 (-5.60%) USD | NASDAQ | Jan 23, 16:00

2.20 +0.01 (+0.46%) After-Hours: 16:48

View Current Deferred Revenue (Quarterly) for SAVA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

cbdMD, Inc.	Upgrade
BioMarin Pharmaceutical, Inc.	--
Amicus Therapeutics, Inc.	--
Geron Corp.	--
NovaBay Pharmaceuticals, Inc.	--